BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Epsilon-polylysine Hydrochloride | Epsilon-polylysine, an innate cationic antimicrobial polypeptide enlisted as a preservative in the edibles and cosmetics trade, is equipped with a diverse spectrum bactericidal capability aimed at the annihilation of deadly microorganisms like E. coli as well as Staphylococcus aureus. As a matter of fact, researchers are exploring this particular polypeptide's prowess to be employed as a promising therapeutic intervention for curbing antibiotic-resistant bacterial infections. Group: Pharmaceutical. CAS No. 28211-04-3. Pack Sizes: 100 g. Product ID: B0001-011213. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Eptifibatide | An arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events. Uses: Platelet aggregation inhibitors. Group: Pharmaceutical. CAS No. 188627-80-7. Pack Sizes: 25 mg. Product ID: BAT-006126. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| EPZ011989 | EPZ011989 is a potent, orally-available EZH2 inhibitor with robust in vivo activity. EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma. Group: Pharmaceutical. CAS No. 1598383-40-4. Pack Sizes: 50 mg. Product ID: B0084-470873. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| EPZ015666 | EPZ015666 shows potent cellular activity that blocks symmetric dimethylation of SmD3 and inhibit proliferation of MCL cell lines (Z-138, Granta-519, Maver-1, Mino, and Jeko-1) with IC50 of 96-904 nM. Group: Pharmaceutical. CAS No. 1616391-65-1. Pack Sizes: 300 mg. Product ID: B0084-463445. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| EPZ015866 | EPZ015866,also called as GSK591, is a chemical probe for PRMT5 which has a role in diverse cellular processes including tumorigenesis. It exhibits excellent selectivity against a panel of methyltransferases. Inhibits the PRMT5/MEP50 complex from methylati. Group: Pharmaceutical. CAS No. 1616391-87-7. Pack Sizes: 300 mg. Product ID: B0084-474632. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| EPZ-6438 | EPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. EPZ-6438 induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells. Treatment of xenograft-bearing mice with EPZ-6438 leads to dose-dependent regression of MRTs with correlative diminution of intratumoral trimethylation levels of lysine 27 on histone H3, and prevention of tumor regrowth after dosing cessation. These data demonstrate the dependency of SMARCB1 mutant MRTs on EZH2 enzymatic activity and portend the utility of EZH2-targeted drugs for the treatment of these genetically defined cancers. EPZ-6438 is currently in clinical trials. Group: Pharmaceutical. CAS No. 1403254-99-8. Pack Sizes: 1 g. Product ID: B0084-462339. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Equilenin Impurities | Equilenin Impurities stand as fundamental components in pharmaceutical investigation, crucial for decoding hormone replacement synthesis complexities linked to menopausal conditions. They provide insights into drug purity interrogation and efficacy evaluation, ensuring augmented safety and therapeutic precision, thereby elevating medical application effectiveness and optimizing patient care strategies in estrogen-related treatments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Equilin Impurities | Equilin Impurities, specialized in studying hormone replacement therapies, play a crucial role in pharmaceutical quality control. These impurities are essential for developing advanced treatment options for menopausal symptoms and osteoporosis. Their accurate characterization enhances the efficacy and safety of drugs containing equilin, contributing significantly to women's health therapeutics. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erastin | Erastin is an antitumor agent selective for tumor cells bearing oncogenic RAS (i.e. HRAS, KRAS). Erastin produces non-apoptotic tumor cell death by altering mitochondrial voltage-dependent anion channel (VDAC) gating allowing cations to enter mitochondria and leading to release of oxidative species causing oxidative cell death. Erastin blocks and reverses mitochondrial depolarization after microtubule destabilizers in intact cells and antagonized tubulin-induced VDAC blockage in planar bilayers. Reversal of tubulin-VDAC interaction by erastin antagonizes Warburg metabolism and restores oxidative mitochondrial metabolism. Group: Pharmaceutical. CAS No. 571203-78-6. Pack Sizes: 100 mg. Product ID: B0084-300990. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erdafitinib | Erdafitinib, also known as JNJ-42756493, is a potent and selective orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Group: Pharmaceutical. CAS No. 1346242-81-6. Pack Sizes: 250 mg. Product ID: B0084-470835. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erdosteine Impurities | Erdosteine Impurities are chemical derivatives used in the characterization and quality control of Erdosteine, a mucolytic agent indicated for chronic obstructive pulmonary disease (COPD). These impurities play a crucial role in ensuring drug purity and efficacy, ultimately supporting the therapeutic management of respiratory conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ergocristine Impurities | Ergocristine Impurities, crucial in the biomedical industry, serve as reference standards in the analysis and development of ergot-derived pharmaceuticals. They aid in quality control and safety evaluation, particularly for drugs addressing migraines and other vascular ailments. These impurities provide insights for pharmaceutical research and regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ergosterol | Ergosterol is a sterol and a biological precursor (a provitamin) to vitamin D2. Uses: Antitumor. Group: Pharmaceutical. CAS No. 57-87-4. Pack Sizes: 100 mg. Product ID: NP6079. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Eribulin Impurities | Eribulin Impurities, integral in the biomedical industry, are utilized for the development and quality control of eribulin mesylate, a prominent chemotherapeutic agent. Eribulin is primarily employed in the treatment of metastatic breast cancer and liposarcoma, making these impurities essential in ensuring drug safety, efficacy, and regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Eribulin Mesylate | Eribulin Mesylate is an antitumor drug that can be used to treat patients with metastatic breast cancer. It inhibits the proliferation of cancer cells by binding tubulin and microtubules. Eribulin Mesylate can inhibit experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Uses: The treatmnet of breast cancer. Group: Pharmaceutical. CAS No. 441045-17-6. Pack Sizes: 1 mg. Product ID: BADC-01399. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Eriocalyxin B | Eriocalyxin B, isolated from the herbs of Isodon eriocalyx, is a potent NF-kappaB inhibitor. Eriocalyxin B inhibited the NF-kappaB transcriptional activity but not that of cAMP response element-binding protein. eriocalyxin B reversibly interfered with the binding of p65 and p50 subunits to the DNA in a noncompetitive manner. Eriocalyxin B exerts potent antiinflammatory effects through selective modulation of pathogenic Th1 and Th17 cells by targeting critical signaling pathways. Besides, Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways. Eriocalyxin B should be considered a candidate for pancreatic cancer treatment. Uses: Antiinflammatory. Group: Pharmaceutical. CAS No. 84745-95-9. Pack Sizes: 1 mg. Product ID: NP1304. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Eriocitrin | Eriocitrin is a powerful antioxidative flavonoid in lemon with lipid-lowering effects in a rat model of high-fat diet. It might play an important role in the control of the change in glutathione redox status in rat liver during exercise. These findings showed that Eriocitrin was effective in the prevention of oxidative damages caused by acute exercise-induced oxidative stress. Eriocitrin was suggested to be metabolized by intestinal bacteria, and then eriodictyol and 3,4-dihydroxyhydrocinnamic of its metabolite were absorbed. Following administration of Eriocitrin, plasma exhibited an elevated resistance effect to lipid peroxidation. Eriocitrin metabolites functioning as antioxidant agents are discussed. Uses: Antioxidant. Group: Pharmaceutical. CAS No. 13463-28-0. Pack Sizes: 25 mg. Product ID: B2703-465065. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Eriodictyol | Eriodictyol is a natural flavonoid found in the fruits of Citrus sinensis (L.) Osbeck. Eriodictyol exhibits activities of antidiabetic, anti-inflammatory and antioxidant. Eriodictyol can increases glucose uptake and improves insulin resistance. Group: Pharmaceutical. CAS No. 552-58-9. Pack Sizes: 10 mg. Product ID: NP2540. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Eriodictyol 7,3'-dimethyl ether | Eriodictyol 7,3'-dimethyl ether is a natural compound isolated from the herbs of Blumea balsamifera. Group: Pharmaceutical. CAS No. 54352-60-2. Pack Sizes: 1 mg. Product ID: NP2427. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Eriodictyol 7-O-glucoside | Eriodictyol 7-O-glucoside is isolated from the herbs of Dracocephalum rupestre. It has protective effect on cisplatin-induced toxicity. Group: Pharmaceutical. CAS No. 38965-51-4. Pack Sizes: 5 mg. Product ID: NP1941. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erlotinib | Erlotinib is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Erlotinib has been indicated for non-small cell lung cancer (NSCLC) and pancreatic cancer therapy. Group: Pharmaceutical. CAS No. 183321-74-6. Pack Sizes: 10 g. Product ID: NP3245. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erlotinib-[d6] Hydrochloride | Erlotinib-[d6] Hydrochloride is the labelled analogue of Erlotinib. Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity. Erlotinib is a medication used to treat non-small cell lung cancer and pancreatic cancer. Group: Pharmaceutical. CAS No. 1189953-78-3. Pack Sizes: 5 mg. Product ID: BLP-006076. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erlotinib hydrochloride | Erlotinib HCl potently inhibits EGFR activation in intact cells including HNS human head and neck tumor cells (IC50 = 20 nM), DiFi humancolon cancer cells and MDA MB-468 human breast cancer cells. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 183319-69-9. Pack Sizes: 25 g. Product ID: BBF-04613. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erlotinib Impurities | Erlotinib Impurities occupy a vital niche within quality assurance and synthetic processes related to Erlotinib, a crucial tyrosine kinase inhibitor targeting non-small cell lung and pancreatic cancers. Examination of these impurities ensures treatment efficacy and safety, fostering advancements in oncology therapeutic protocols, thus highlighting their indispensable role in medical progress. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erlotinib Impurity 8 | A metabolite of Erlotinib. Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity. Group: Pharmaceutical. CAS No. 328528-74-1. Pack Sizes: 25 mg. Product ID: B2694-471125. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erlotinib O-Desmethyl Metabolite Isomer (M14) HCl | OSI-420 (CP-473420) is an active metabolite of erlotinib which is an orally active EGFR tyrosin kinase inhibitor with IC50 of 2 and 20 nM for the inhibition of human EGFR and EGFR autophosphorylation in tumor cells. Uses: For research used only. Group: Pharmaceutical. CAS No. 183320-51-6. Pack Sizes: 10 mg. Product ID: B0084-286627. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ertapenem Impurities | Ertapenem Impurities are chemical derivatives that play a crucial role in the quality control and stability analysis of the antibiotic Ertapenem, used to treat bacterial infections. These impurities provide essential insight into the drug's synthesis process, ensuring safety and efficacy in combating multidrug-resistant bacterial strains. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ertapenem Sodium | Ertapenem Sodium is the sodium salt of ertapenem. Ertapenem has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of ertapenem results from the inhibition of cell wall synthesis and is mediated through ertapenem binding to penicillin binding proteins (PBPs). In Escherichia coli, it has strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preference for PBPs 2 and 3. Ertapenem is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases. Ertapenem is hydrolyzed by metallo-beta-lactamases. Ertapenem has been shown to be active against most isolates of the following microorganisms in vitro and in clinical infections. Group: Pharmaceutical. CAS No. 153773-82-1. Pack Sizes: 1 g. Product ID: BBF-03993. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ertugliflozin | PF-04971729, a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is developed for the treatment of diabetes mellitus. Inhibitory effects against the organic cation transporter 2-mediated uptake of [14C]metformin by PF-04971729 is very weak (IC50 = 900μM). Uses: Sodium-glucose transporter 2 inhibitors. Group: Pharmaceutical. CAS No. 1210344-57-2. Pack Sizes: 100 mg. Product ID: B2693-452980. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ervamycine | Ervamycine is a natural alkaloid isolated from the herbs of Melodinus khasianus. Group: Pharmaceutical. CAS No. 27773-39-3. Pack Sizes: 5 mg. Product ID: NP0354. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erythrartine | Erythrartine is a natural alkaloid isolated from the bark of Erythrina variegata Linn. Group: Pharmaceutical. CAS No. 51666-26-3. Pack Sizes: 1 mg. Product ID: NP0386. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erythrinin C | Erythrinin C is a natural plant flavonoid isolated from the seeds of Psoralea corylifolia Linn. Group: Pharmaceutical. CAS No. 63807-85-2. Pack Sizes: 1 mg. Product ID: NP2445. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (+)-Erythristemine | Erythristemine is a natural alkaloid found in the barks of Aralia chinensis. Group: Pharmaceutical. CAS No. 28619-41-2. Pack Sizes: 5 mg. Product ID: NP0382. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erythromycin A iminoether | An impurity of Azithromycin. Azithromycin, derived from erythromycin, is an antibiotic. It binds to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA. It is an azalide, a subclass of macrolide antibiotics and is one of the world's best-selling antibiotics. Group: Pharmaceutical. CAS No. 161193-44-8. Pack Sizes: 100 mg. Product ID: B0864-471157. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erythromycin EP Impurity N | An impurity of Erythromycin. Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by targeting the 56S ribosomal subunit, blocking the progression of nascent polypeptide chains. Group: Pharmaceutical. CAS No. 3225-82-9. Pack Sizes: 1 mg. Product ID: B2694-471158. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erythromycin Impurities | Erythromycin Impurities, present in the synthesis of erythromycin, play a critical role in the pharmaceutical industry by providing insight into the drug's stability and purity. These impurities are utilized to evaluate the effects of erythromycin in treating bacterial infections and optimizing the formulation for enhanced therapeutic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Erythromycylamine | Erythromycylamine is a macrolide antibiotic and an active metabolite of dirithromycin. It is active against a variety of bacteria, including strains of S. pyogenes, S. pneumoniae, L. monocytogenes and B. pertussis. A derivative of Erythromycin. Group: Pharmaceutical. CAS No. 26116-56-3. Pack Sizes: 50 mg. Product ID: BBF-04636. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Escin | Escin is an exquisite arboreal extract used for studying vascular disorders and revered for its profound anti-inflammatory attributes. Group: Pharmaceutical. CAS No. 6805-41-0. Pack Sizes: 1 g. Product ID: NP2599. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Escin Ia | Escin Ia is a triterpenoid saponin isolated from A. chinensis. It was shown to inhibit HIV-1 protease with IC50 value of 35 μM. Group: Pharmaceutical. CAS No. 123748-68-5. Pack Sizes: 10 mg. Product ID: NP7065. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Escitalopram | Escitalopram, the S-enantiomer of citalopram, belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Escitalopram may be used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of escitalopram is found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Escitalopram does not inhibit monoamine oxidase. Uses: Serotonin uptake inhibitors; antidepressive agents, second-generation. Group: Pharmaceutical. CAS No. 128196-01-0. Pack Sizes: 500 mg. Product ID: B2693-461840. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Escitalopram Impurities | Escitalopram Impurities are crucial reference standards in pharmaceutical research for assessing the purity, stability, and efficacy of the antidepressant escitalopram. They facilitate understanding the drug's metabolic and degradation pathways, ensuring the production of safe, high-quality escitalopram formulations for treating depression and generalized anxiety disorder. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Escitalopram oxalate | Escitalopram Oxalate, also known by the brand names Lexapro and Cipralex among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults and children over 12 years of age with major depressive disorder (MDD) and generalized anxiety disorder (GAD). Group: Pharmaceutical. CAS No. 219861-08-2. Pack Sizes: 10 g. Product ID: NP3630. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esculentic acid | Esculentic acid has been isolated from the roots of Phytolacca acinosa Roxb. It has protective effects against LPS-induced endotoxic shock. Esculentic acid is a selective COX-2 inhibitor and has anti-inflammatory effect. Uses: Anti-inflammatory effect. Group: Pharmaceutical. CAS No. 103974-74-9. Pack Sizes: 5 mg. Product ID: NP6746. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esculetin | Esculetin is isolated from the peel of Aesculus hippocastanum L. It can quench the inner fluorescence of bovine serum albumin. Esculetin has various biological and pharmaceutical properties including anti-edema, anti-inflammatory, anti-tumour, hepatoprotective, anti-osteoarthritis and anti-rheumatoid arthritis effects. Uses: Anticoagulant effect; antifungal; antiinflammatory. Group: Pharmaceutical. CAS No. 305-01-1. Pack Sizes: 10 g. Product ID: NP1136. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esculin | Esculin is a glucoside found in horse chestnuts. Esculin is a bittering agent. Naringin dihydrochalcone obtained by hydrolysis and hydrogenation of this product is a sweetener with a sweetness of about 150 times that of sucrose. Esculin protects cells against DNA damage and reduces ROS levels. Carcinogenesis inhibitor. Uses: Antiflogistic, cytostatic, and antimutagenic. Group: Pharmaceutical. CAS No. 531-75-9. Pack Sizes: 25 g. Product ID: NP1140. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ESI-08 | ESI-08 is a potent and selective EPAC antagonist that completely inhibits both EPAC1 and EPAC2 activity (IC50 = 8.4 μM for EPAC2) without inhibition of cAMP-mediated PKA activation. Group: Pharmaceutical. CAS No. 301177-43-5. Pack Sizes: 50 mg. Product ID: B1370-379925. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esmolol Dimer | Esmolol Dimer is an impurity of Esmolol. Esmolol is a cardioselective β-blocker which has a rapid onset but short duration of action without causing significant intrinsic sympathomimetic or membrane stabilizing activities at recommended therapeutic doses. Group: Pharmaceutical. CAS No. 98903-89-0. Pack Sizes: 20 mg. Product ID: B2694-471172. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esmolol Impurities | Esmolol Impurities fulfill a vital role within the realm of quality control and analytical analysis of the cardioselective beta-1 adrenergic antagonist, esmolol. These impurities are crucial in deciphering the drug's stability, therapeutic potential, and safety metrics, particularly in managing supraventricular tachycardia and acute hypertension, thereby ensuring refined pharmacological insights. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esmolol Impurity 1 | Esmolol Impurity 1 is an impurity of Esmolol. Esmolol is a cardioselective β-blocker which has a rapid onset but short duration of action without causing significant intrinsic sympathomimetic or membrane stabilizing activities at recommended therapeutic doses. Group: Pharmaceutical. CAS No. 81147-94-6. Pack Sizes: 5 mg. Product ID: B2694-135716. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esomeprazole Impurities | Esomeprazole Impurities, as a quintessential aspect of pharmaceutical research, critically influence the domains of quality control and assurance within esomeprazole pharmacology. These impurities enable the meticulous assessment of drug purity, stability, and efficacy, especially in treating acid-related conditions such as GERD and peptic ulcers, thus upholding superior pharmaceutical standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esomeprazole Impurity 22 | Esomeprazole Impurity 22 is an impurity of Esomeprazole. Esomeprazole is the (S)-(-)-enantiomer of omeprazole, a medication of the proton pump inhibitor class used for the treatment of gastroesophageal reflux disease (GERD) and gastric ulcer. Group: Pharmaceutical. CAS No. 727375-13-5. Pack Sizes: 5 mg. Product ID: B0025-007871. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esomeprazole Impurity H215/02 | Esomeprazole Impurity H215/02 is an impurity of Esomeprazole. Esomeprazole is the (S)-(-)-enantiomer of omeprazole, a medication of the proton pump inhibitor class used for the treatment of gastroesophageal reflux disease (GERD) and gastric ulcer. Group: Pharmaceutical. CAS No. 1803449-02-6. Pack Sizes: 5 mg. Product ID: B0025-007870. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esomeprazole Impurity K | An impurity of Esomeprazole. Esomeprazole is the (S)-(-)-enantiomer of omeprazole, a medication of the proton pump inhibitor class used for the treatment of gastroesophageal reflux disease (GERD) and gastric ulcer. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: B0025-007868. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esomeprazole magnesium trihydrate | Esomeprazole magnesium trihydrate acts as a gastric proton pump inhibitor (PPI). In adults, esomeprazole is indicated for the treatment and maintenance of healing of erosive esophagitis, relieving of GERD symptoms; reduction of the risk for NSAID-associated gastric acid production. Group: Pharmaceutical. CAS No. 217087-09-7. Pack Sizes: 100 g. Product ID: B2692-087603. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Esreboxetine Impurities | Esreboxetine Impurities hold a vital position within the biomedical domain, integral to quality assurance and validation processes during esreboxetine synthesis. By identifying potential degradants, these impurities ensure the medication's efficacy and safety, crucial for therapeutic applications in attention deficit hyperactivity disorder (ADHD) and alleviating neuropathic pain. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)- | Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)- (CAS# 875573-66-3 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 875573-66-3. Pack Sizes: 1 g. Product ID: B2699-099664. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estradiol | Estradiol, or more precisely, 17β-estradiol, is a human sex hormone and steroid, and the primary female sex hormone. It is essential for the maintenance of fertility and secondary sexual characteristics in females. Uses: Human sex hormone. Group: Pharmaceutical. CAS No. 50-28-2. Pack Sizes: 25 g. Product ID: NP6102. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estradiol Impurities | Estradiol Impurities, integral to the biomedical sector, are essential benchmarks ensuring the integrity of estradiol formulations. They underlie stringent quality control processes in hormone therapy development, addressing menopausal and osteoporotic conditions while safeguarding therapeutic efficacy and safety through meticulous standardization and verification practices. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estratetraenol | Estratetraenol is a steroid produced by women having pheromone-like activities. Group: Pharmaceutical. CAS No. 1150-90-9. Pack Sizes: 100 mg. Product ID: B1370-081979. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estriol | Estriol is a metabolite of 17β-estradiol with much lower biological activity. It is the primary estrogen found in the urine. Large quantities of estriol and estrone are produced by the placenta during pregnancy. These are also the primary estrogens produced by adipose tissue in men and in post-menopausal women. Group: Pharmaceutical. CAS No. 50-27-1. Pack Sizes: 20 g. Product ID: B0084-093184. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estriol Impurities | Estriol Impurities are critical in the pharmaceutical research sector for developing and refining estrogen-related drugs. These impurities aid in understanding estrogen hormone metabolism, contributing to treatments for menopausal symptoms, osteoporosis, and hormone-sensitive cancers, ensuring drug safety and efficacy in therapeutics related to estriol. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estromustine | Estromustine is a metabolite of estramustine phosphate, an antineoplastic agent used for the treatment of prostate cancer. Group: Pharmaceutical. CAS No. 62899-40-5. Pack Sizes: 10 mg. Product ID: B2699-135731. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estrone | Estrone is one of the three naturally occurring estrogens, the others being estradiol and estriol. Estrone is synthesized from androstenedione by the aromatase enzyme system in the ovaries and placenta, and is also synthesized from estradiol by 17-hydroxy steroid dehydrogenase in the liver. Serum concentrations of estrone in premenopausal women fluctuate according to the menstral cycle and becomes the most predominant estrogen in postmenopausal women. The binding affinities of estrone to the estrogen receptors α and β are approximately 60% and 37% relative to estradiol. Group: Pharmaceutical. CAS No. 53-16-7. Pack Sizes: 50 g. Product ID: NP6101. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Estrone Impurities | Estrone Impurities hold a critical position within pharmaceutical research, advancing the refinement and purity validation of estrone-based hormonal therapies. These substances play a fundamental role in the meticulous detection and characterization of by-products, thereby strengthening quality control measures for medications targeting menopausal symptoms, osteoporosis, and estrogen-linked conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ETC-1002 | ETC-1002 is a novel, first-in-class, orally available, once-daily LDL-C lowering small molecule and is activator of hepatic AMP-activated protein kinase (AMPK). It also has potent inhibitory activity against hepatic ATP-citrate lyase. Group: Pharmaceutical. CAS No. 738606-46-7. Pack Sizes: 250 mg. Product ID: B0084-463320. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Etelcalcetide hydrochloride | Etelcalcetide is a calcium-sensing receptor agonist as a D-amino peptide calcimimetic for the treatment of secondary hyperparathyroidism. It can bind to and activate the CaSR (calcium-sensing receptor) in the parathyroid gland as an allosteric activator, resulting in PTH reduction and suppression. Amgen Inc. announced its submission of a New Drug Application to the FDA for etelcalcetide in Aug 2015. Group: Pharmaceutical. CAS No. 1334237-71-6. Pack Sizes: 10 mg. Product ID: B0084-475311. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ethambutol Impurities | Ethambutol Impurities assume a crucial role in the progressive refinement of anti-tuberculosis pharmaceutics, where their meticulous examination assures the effectiveness and safety of ethambutol compositions. By facilitating purity enhancement, such impurities bolster therapeutic efficacy against Mycobacterium tuberculosis, thus underpinning the advancement of treatment modalities in combating this infectious disease. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ethane Impurities | Ethane Impurities, often detected in hydrocarbon processing, hold significance in biomedical research for their potential impact on respiratory health and carcinogenesis. Understanding these impurities aids in developing safety standards and evaluation guidelines for chemical exposure, highlighting their role in preventative medicine and public health initiatives. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ethanesulfonic acid, 2,2'-trithiodi-, disodium salt | Ethanesulfonic acid, 2,2'-trithiodi-, disodium salt. Group: Pharmaceutical. CAS No. 16208-48-3. Pack Sizes: 100 mg. Product ID: BB076997. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ethanol, 2-(2-ethoxyphenoxy)-, methanesulfonate | One of the impurities of Tamsulosin, which is an α1-adrenoceptor antagonist and could be used against benign prostatic hypertrophy. Group: Pharmaceutical. CAS No. 169506-15-4. Pack Sizes: 50 mg. Product ID: B1370-278994. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.